Fragile X syndrome

Jump to navigation Jump to search

For patient information click here

Fragile X syndrome
Location of FMR1 gene
ICD-10 Q99.2
ICD-9 759.83
OMIM 309550
DiseasesDB 4973
MeSH D005600

Fragile X syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Fragile X syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Fragile X syndrome On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Fragile X syndrome

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Fragile X syndrome

CDC on Fragile X syndrome

Fragile X syndrome in the news

Blogs on Fragile X syndrome

Directions to Hospitals Treating Fragile X syndrome

Risk calculators and risk factors for Fragile X syndrome

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and keywords:: Martin-bell syndrome; marker X syndrome, escalante's syndrome

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Fragile X syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

There are no established risk factors for Fragile X syndrome. However, the child with family history of Fragile x Syndrome, autism disorder of unknown cause, developmental delay, adult onset ataxia/tremor or any intellectual disabilities are at greater risk of developing the disorder. [1]

Screening

Genetic counseling and prenatal screening is recommended when one of the parents is shown to be a carrier of fragile X. Prenatal testing can be done by amniocentesis at 16-20 weeks or by chorionic villus sampling (CVS) at 10-13 weeks to determine if a fetus has inherited the fragile X gene. [2]

Natural History, Complications and Prognosis

Diagnosis

The diagnosis of Fragile X Syndrome is based upon detection of an alteration in the fragile X mental retardation 1 (FMR1) gene. [3]

History and Symptoms

Physical Examination

Laboratory findings

Other diagnostic studies

Treatment

Medical Therapy | Primary Prevention | Secondary Prevention | Cost Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1


External links

Template:Pervasive developmental disorders Template:Chromosomal abnormalities

Categoyr:Disease state

Template:Link FA

Template:WH Template:WS

  1. 1. Carrier Testing for Fragile X Syndrome [Internet]. ucsfhealth.org. [cited 2021 Jul 15]. Available from: https://www.ucsfhealth.org/Education/Carrier Testing for Fragile X Syndrome
  2. Mak AS, Leung KY (2017). "Challenges in prenatal screening and counselling for fragile X syndrome". Hong Kong Med J. 23 (2): 108–9. doi:10.12809/hkmj175064. PMID 28387201.
  3. Ciaccio C, Fontana L, Milani D, Tabano S, Miozzo M, Esposito S (2017). "Fragile X syndrome: a review of clinical and molecular diagnoses". Ital J Pediatr. 43 (1): 39. doi:10.1186/s13052-017-0355-y. PMC 5395755. PMID 28420439.